These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3100802)

  • 1. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes.
    Roth B; Rauckman BS; Ferone R; Baccanari DP; Champness JN; Hyde RM
    J Med Chem; 1987 Feb; 30(2):348-56. PubMed ID: 3100802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 8. The 3,4,5-triethyl isostere of trimethoprim. A study of specificity.
    Roth B; Aig E
    J Med Chem; 1987 Nov; 30(11):1998-2004. PubMed ID: 3312605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrrolo[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines as conformationally restricted analogues of the antibacterial agent trimethoprim.
    Kuyper LF; Garvey JM; Baccanari DP; Champness JN; Stammers DK; Beddell CR
    Bioorg Med Chem; 1996 Apr; 4(4):593-602. PubMed ID: 8735847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 11. Quinolylmethyl analogues with basic substituents conveying specificity.
    Davis SE; Rauckman BS; Chan JH; Roth B
    J Med Chem; 1989 Aug; 32(8):1936-42. PubMed ID: 2502633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 9. Lipophilic trimethoprim analogues as antigonococcal agents.
    Roth B; Baccanari DP; Sigel CW; Hubbell JP; Eaddy J; Kao JC; Grace ME; Rauckman BS
    J Med Chem; 1988 Jan; 31(1):122-9. PubMed ID: 3121854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines.
    Li RL; Poe M
    J Med Chem; 1988 Feb; 31(2):366-70. PubMed ID: 3276891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 12. 1,2-Dihydroquinolylmethyl analogues with high activity and specificity for bacterial dihydrofolate reductase.
    Johnson JV; Rauchman BS; Baccanari DP; Roth B
    J Med Chem; 1989 Aug; 32(8):1942-9. PubMed ID: 2666668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 10. 2,4-Diamino-5-(6-quinolylmethyl)- and -[(tetrahydro-6-quinolyl)methyl]pyrimidine derivatives. Further specificity studies.
    Rauckman BS; Tidwell MY; Johnson JV; Roth B
    J Med Chem; 1989 Aug; 32(8):1927-35. PubMed ID: 2502632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,4-diamino-5-benzylpyrimidines and analogues as antibacterial agents. 6. A one-step synthesis of new trimethoprim derivatives and activity analysis by molecular modeling.
    Stuart A; Paterson T; Roth B; Aig E
    J Med Chem; 1983 May; 26(5):667-73. PubMed ID: 6341588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 4. 6-Substituted trimethoprim derivatives from phenolic Mannich intermediates. Application to the synthesis of trimethoprim and 3,5-dialkylbenzyl analogues.
    Roth B; Aig E; Lane K; Rauckman BS
    J Med Chem; 1980 May; 23(5):535-41. PubMed ID: 6991695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 2. C-Alkylation of pyrimidines with Mannich bases and application to the synthesis of trimethoprim and analogues.
    Roth B; Strelitz JZ; Rauckman BS
    J Med Chem; 1980 Apr; 23(4):379-84. PubMed ID: 6991692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theory and application of molecular potential energy fields in molecular shape analysis: a quantitative structure--activity relationship study of 2,4-diamino-5-benzylpyrimidines as dihydrofolate reductase inhibitors.
    Hopfinger AJ
    J Med Chem; 1983 Jul; 26(7):990-6. PubMed ID: 6345782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basis of selectivity of antibacterial diaminopyrimidines.
    Baccanari DP; Kuyper LF
    J Chemother; 1993 Dec; 5(6):393-9. PubMed ID: 8195830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 3. C-Benzylation of aminopyridines with phenolic Mannich bases. Synthesis of 1- and 3-deaza analogues of trimethoprim.
    Rauckman BS; Roth B
    J Med Chem; 1980 Apr; 23(4):384-91. PubMed ID: 6991693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analogues.
    Kuyper LF; Roth B; Baccanari DP; Ferone R; Beddell CR; Champness JN; Stammers DK; Dann JG; Norrington FE; Baker DJ
    J Med Chem; 1985 Mar; 28(3):303-11. PubMed ID: 3973902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii.
    Gangjee A; Vasudevan A; Queener SF
    J Med Chem; 1997 Sep; 40(19):3032-9. PubMed ID: 9301665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.